1Wang MC,ValenzueL A,MurphyG P,et al.Purifiction of a human proste specific antigen[J].Invest Urol,1979,17(2):159-163.
2Yu H,Diamandis EP,Levesque M,et al.Prostatespecific antigen in breast cancer benign breast disease and normal breast tissue[J].Breast Cancer Res Treat,1996,40(2):171-178.
3Zhang WM,Leinonen J,Kalkkinen N,et al.Purification and characterization of diferent molecular forms of prostate specific antigen in human seminal fluid[J]Clin Chem,1995,41:1567-1573.
4Majumdar S,Diamandis EP.The promoter and the enhancer region of the KLK3 (prostate specific antigen)gene is frequently mutated in breast tumours and in breast carcinoma cell lines[J].Br J Cancer,1999,79 (9/10):1594-1602.
5Black MH,Magklara A,ObiezuC,et al.Expression of a prostate associated protein,human glandular kallikrein(hK2),in breast tumours and in normal breast secretions[J].Br J Cancer,2000,82(2):361-367.
6Yousef GM,Scorilas A,Chang A,et al.Prostate down regulation of the human kallikrein gene5 (KLK5) in prostate cancer tissues[J].Prostate,2002,51 (2):126-132.
7Lilja H.Seminal vesicle-secreted proteins and their reactions during elation and liquefaction of human semen[J].J Clin Invest,1987,80:281-285.
8Chan J M,StampferM J,Giovannucci E,et al.Plasmain sulin-like growth factor-1 and prostate cancer risk:a prospective study[J].Science,1998,279:563-564.
9Irani J,Levillain P,Geujon JM,et al.Inflammation in benign prostatic hyperplasia:correlation with prostate specific antigen value[J].J Urol,1997; 157 (4):1301-1303.
10Pansadoro V,Emiliozzi P,DefidioL,et al.Prostate specific antigen and prostatitis in men under fifity[J].EurUrol,1996,30(1):24-27.
4Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009[J]. CA: Cancer J Clin, 2009, 59(4): 225-249.
5Chiu JS, Wang YF, Su YC, et al. Artificial neural network to predict skeletal metastasis in patients with prostate cancer [J]. J Med Systems, 2009, 33(2): 91-t00.
6Yahara J, Noguchi M, Noda S. Quantitative evaluation of bone metastases in patients with advanced prostate cancer during systemic treatment[J]. BJU Int, 2003, 92(4): 379.
7Baxter AD, Coakley FV, Finlay DB, et al. The aetiology of solitaryhot spots in thy fibs on planar bone scans [J]. Nucl Med Commun, 1995, 16(10): 834-837.
8James L, Andrew J, Robert R, et al. NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer[J]. Natl Compr Canc Net, 2011, 8(2): 162-200.
9Birtle A J, Freeman A, Masters JR, et al. Clinical features of patients who present with metastatic prostate carcinoma and serum prostate specific antigen (psa) levels<10g/mL: the "PSA negative" patients[J]. Cancer, 2003, 98(11): 2362-2367.
10Mueller-lisse UG, Mueller-lisse UL, Hailer S, et al. Likehood of prostate cancer based on prostate-specific antigen density by MRI: retrospective analysis [J]. J Comput Assist Tomogr, 2002, 26(3): 432-437.
